Skip to main content
. 2023 Nov 15;13(11):5719–5732.

Figure 5.

Figure 5

The distribution of PAM 50 subtypes in (A) ER+/PR+/Her2+ and (B) Her2+ breast cancer patients. (A) Her2-enriched patients were mostly Her2+ (3+), and lum B patients were mostly Her2+ (2+). (B) Her2-enriched patients were mostly Her2+ (3+), and lum B patients were mostly Her2+ (2+).